Table 1 HPV prevalence for specific types and categories, both overall and by age group (n = 4987)*.
Prevalence by age group, % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Category, HPV type (alpha species) | No. | Overall prevalence, % | 20-24 (n = 117) | 25-29 (n = 526) | 30-34 (n = 825) | 35-39 (n = 1102) | 40-44 (n = 1041) | 45-49 (n = 704) | 50-54 (n = 368) | 55-79 (n = 304) |
Any type | 665 | 13.3 | 16.2 | 12.9 | 11.0 | 13.9 | 13.6 | 13.2 | 17.7 | 11.2 |
Established HR types | ||||||||||
Any established HR types | 508 | 10.2 | 14.5 | 9.3 | 8.4 | 10.7 | 10.7 | 9.2 | 14.4 | 8.6 |
16 (alpha-9) | 123 | 2.5 | 1.7 | 2.5 | 2.2 | 2.4 | 2.1 | 2.8 | 4.1 | 2.3 |
18 (alpha-7) | 39 | 0.8 | 0.9 | 0.6 | 0.8 | 0.9 | 1.2 | 0.4 | 0.5 | 0.3 |
31 (alpha-9) | 39 | 0.8 | 1.7 | 1.0 | 0.4 | 1.3 | 0.5 | 0.4 | 0.8 | 1.3 |
33 (alpha-9) | 38 | 0.8 | 2.6 | 1.0 | 0.6 | 0.7 | 0.7 | 0.4 | 1.4 | 0.7 |
35 (alpha-9) | 9 | 0.2 | 0.9 | 0.0 | 0.4 | 0.0 | 0.1 | 0.1 | 0.5 | 0.3 |
39 (alpha-7) | 13 | 0.3 | 0.0 | 0.2 | 0.4 | 0.1 | 0.4 | 0.0 | 0.0 | 1.3 |
45 (alpha-7) | 16 | 0.3 | 0.9 | 0.8 | 0.2 | 0.1 | 0.4 | 0.4 | 0.0 | 0.3 |
51 (alpha-5) | 46 | 0.9 | 0.0 | 1.3 | 1.0 | 0.5 | 0.6 | 0.6 | 2.2 | 2.3 |
52 (alpha-9) | 155 | 3.1 | 3.4 | 2.1 | 2.7 | 3.4 | 3.8 | 3.3 | 3.3 | 2.0 |
56 (alpha-6) | 21 | 0.4 | 1.7 | 0.4 | 0.1 | 0.2 | 0.4 | 0.6 | 1.1 | 0.7 |
58 (alpha-9) | 106 | 2.1 | 3.4 | 2.3 | 1.8 | 1.9 | 2.0 | 1.8 | 3.5 | 2.3 |
59 (alpha-7) | 33 | 0.7 | 0.0 | 1.1 | 0.6 | 1.0 | 0.2 | 0.3 | 1.1 | 1.0 |
Probably HR types | ||||||||||
Any probably HR types | 120 | 2.4 | 4.3 | 3.2 | 1.3 | 2.4 | 1.6 | 3.1 | 4.1 | 2.3 |
26 (alpha-5) | 3 | 0.1 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.3 | 0.0 |
53 (alpha-6) | 39 | 0.8 | 2.6 | 0.6 | 0.6 | 0.7 | 0.5 | 0.7 | 1.4 | 1.6 |
66 (alpha-6) | 27 | 0.5 | 0.0 | 1.3 | 0.1 | 0.5 | 0.3 | 0.9 | 0.8 | 0.3 |
68 (alpha-7) | 52 | 1.0 | 1.7 | 1.1 | 0.5 | 1.2 | 0.8 | 1.7 | 1.6 | 0.3 |
82 (alpha-5) | 2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
Established LR types | ||||||||||
Any established LR types | 137 | 2.7 | 2.6 | 2.3 | 2.3 | 2.7 | 2.8 | 2.3 | 4.3 | 3.9 |
6 (alpha-10) | 10 | 0.2 | 0.0 | 0.2 | 0.2 | 0.0 | 0.2 | 0.0 | 0.0 | 1.6 |
11 (alpha-10) | 11 | 0.2 | 0.0 | 0.2 | 0.4 | 0.3 | 0.2 | 0.0 | 0.3 | 0.3 |
40 (alpha-8) | 1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
42 (alpha-1) | 22 | 0.4 | 1.7 | 0.4 | 0.4 | 0.3 | 0.5 | 0.3 | 0.5 | 1.0 |
43 (alpha-8) | 14 | 0.3 | 0.0 | 0.0 | 0.2 | 0.5 | 0.4 | 0.1 | 0.5 | 0.0 |
44 (alpha-10) | 29 | 0.6 | 0.0 | 0.6 | 0.4 | 0.7 | 0.9 | 0.6 | 0.5 | 0.0 |
54 (alpha-13) | 1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
61 (alpha-3) | 8 | 0.2 | 0.0 | 0.2 | 0.2 | 0.1 | 0.0 | 0.3 | 0.5 | 0.0 |
81 (alpha-3) | 46 | 0.9 | 0.9 | 0.4 | 0.5 | 1.0 | 0.8 | 1.1 | 2.2 | 1.3 |
89 (alpha-3) | 2 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Undetermined types | ||||||||||
Any undetermined types | 13 | 0.3 | 0.0 | 0.2 | 0.6 | 0.3 | 0.2 | 0.3 | 0.0 | 0.0 |
13 (alpha-10) | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
57 (alpha-4) | 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
62 (alpha-3) | 4 | 0.1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 |
64 (alpha-11) | 1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
83 (alpha-3) | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
85 (alpha-7) | 1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
86 (alpha-3) | 1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
87 (alpha-3) | 2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Vaccine types | ||||||||||
16 or 18 | 153 | 3.1 | 2.6 | 2.7 | 2.8 | 3.1 | 3.1 | 3.1 | 4.6 | 2.6 |
16+18 | 9 | 0.2 | 0.0 | 0.4 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
6 or 11 or 16 or 18 | 174 | 3.5 | 2.6 | 3.0 | 3.4 | 3.4 | 3.5 | 3.1 | 4.9 | 4.6 |
Single-type infections | 489 | 9.8 | 12.0 | 9.3 | 7.9 | 10.7 | 10.7 | 10.4 | 10.9 | 6.2 |
Multiple-type infections | 176 | 3.5 | 4.3 | 3.6 | 3.2 | 3.2 | 3.0 | 2.8 | 6.8 | 4.9 |
Alpha-1 type infections | 22 | 0.4 | 1.7 | 0.4 | 0.4 | 0.3 | 0.5 | 0.3 | 0.5 | 1.0 |
Alpha-3 type infections | 62 | 1.2 | 0.9 | 0.6 | 1.5 | 1.2 | 0.8 | 1.7 | 2.4 | 1.3 |
Alpha-4 type infections | 2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 |
Alpha-5 type infections | 51 | 1.0 | 0.0 | 1.5 | 1.1 | 0.5 | 0.8 | 0.6 | 2.4 | 2.3 |
Alpha-6 type infections | 81 | 1.6 | 3.4 | 2.3 | 0.8 | 1.4 | 1.1 | 2.0 | 3.0 | 2.3 |
Alpha-7 type infections | 147 | 2.9 | 3.4 | 3.6 | 2.3 | 3.2 | 2.9 | 2.6 | 3.3 | 3.3 |
Alpha-8 type infections | 15 | 0.3 | 0.0 | 0.2 | 0.2 | 0.5 | 0.4 | 0.1 | 0.5 | 0.0 |
Alpha-9 type infections | 409 | 8.2 | 12.8 | 6.7 | 6.8 | 8.6 | 8.5 | 8.0 | 11.4 | 7.2 |
Alpha-10 type infections | 51 | 1.0 | 0.0 | 1.0 | 1.0 | 1.1 | 1.2 | 0.6 | 0.8 | 2.0 |
Alpha-11 type infections | 1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Alpha-13 type infections | 1 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |